Oramed Pharmaceuticals Inc (ORMP)

[trendmkr]

Oramed to present at the American Diabetes Association 76th Scientific Sessions

JERUSALEM, June 9, 2016 /PRNewswire/ —

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that a scientific abstract summarizing a study performed in animals with its orally ingestible insulin capsule, ORMD-0801, will be presented in a poster at the ADA 76th Scientific Sessions on June 11-13, 2016 in New Orleans. The poster was also selected to be included in a moderated tour of select posters.

The American Diabetes Association 76th Scientific Sessions

Poster title: “Pharmacokinetic and Pharmacodynamic Profiles of Orally, Duodenally and Subcutaneously Delivered Insulin in Beagle Canines”

Date: June 11-13, 2016

Location: The Ernest N. Morial Convention Center in New Orleans

About the American Diabetes Association (ADA) Scientific Sessions

The American Diabetes Association’s Scientific Sessions offers researchers and health care professionals from around the world the unique opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care. Some 16,000 people are expected to attend.